The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has recommended approval of daridorexant (Quviviq, Idorsia Pharmaceuticals) for the treatment of insomnia. Daridorexant is a dual orexin receptor antagonist that has been shown to increase sleep induction, improve sleep maintenance, and improve daytime functioning. The drug is indicated for the […]
Tag Archives: Daridorexant
FRIDAY, Feb. 4, 2022 (HealthDay News) — Daridorexant (50 mg) improves both nighttime symptoms and daytime functioning in people with insomnia disorder, according to a study published in the Feb. 1 issue of The Lancet Neurology. Emmanuel Mignot, M.D., from the Stanford Center for Sleep Research and Medicine in Palo Alto, California, and colleagues conducted […]